These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 26890683)

  • 1. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador.
    Cremer ML; Maza M; Alfaro KM; Kim JJ; Ditzian LR; Villalta S; Alonzo TA; Felix JC; Castle PE; Gage JC
    J Low Genit Tract Dis; 2016 Apr; 20(2):145-50. PubMed ID: 26890683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.
    Cremer M; Maza M; Alfaro K; Morales Velado M; Felix J; Castle PE; Kim J; Gage JC
    J Low Genit Tract Dis; 2017 Jan; 21(1):26-32. PubMed ID: 27922905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
    Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.
    Campos NG; Alfaro K; Maza M; Sy S; Melendez M; Masch R; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M; Kim JJ
    Prev Med; 2020 Feb; 131():105931. PubMed ID: 31765712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
    Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
    Pimple S; Shastri SS
    Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador.
    Alfaro K; Maza M; Felix JC; Gage JC; Castle PE; Alonzo TA; Chacón A; González E; Soler M; Conzuelo-Rodriguez G; Masch R; Cremer M
    JCO Glob Oncol; 2020 Oct; 6():1519-1530. PubMed ID: 33064628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexican Cervical Cancer Screening Study II: 6-month and 2-year follow-up of HR-HPV women treated with cryotherapy in a low-resource setting.
    Starks D; Arriba LN; Enerson CL; Brainard J; Nagore N; Chiesa-Vottero A; Uribe JV; Belinson J
    J Low Genit Tract Dis; 2014 Oct; 18(4):333-7. PubMed ID: 24977628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of electronic health record-based tools to improve appropriate use of the human papillomavirus test in adult women.
    Broach V; Day L; Barenberg B; Huang S; Kenton K; White P
    J Low Genit Tract Dis; 2014 Jan; 18(1):26-30. PubMed ID: 23959296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting.
    Banerjee D; Mandal R; Mandal A; Ghosh I; Mittal S; Muwonge R; Lucas E; Basu P
    Asian Pac J Cancer Prev; 2020 May; 21(5):1391-1398. PubMed ID: 32458647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
    Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
    Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE; Reid J; Dockter J; Getman D
    J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program.
    Alfaro KM; Gage JC; Rosenbaum AJ; Ditzian LR; Maza M; Scarinci IC; Miranda E; Villalta S; Felix JC; Castle PE; Cremer ML
    BMC Public Health; 2015 Oct; 15():1058. PubMed ID: 26474762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatability by cryotherapy in a screen-and-treat strategy.
    Gage JC; Rodriguez AC; Schiffman M; Garcia FM; Long RL; Budihas SR; Herrero R; Burk RD; Jeronimo J
    J Low Genit Tract Dis; 2009 Jul; 13(3):174-81. PubMed ID: 19550216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Cost Instructional Apparatus to Improve Training for Cervical Cancer Screening and Prevention.
    Parra S; Oden M; Schmeler K; Richards-Kortum R;
    Obstet Gynecol; 2019 Mar; 133(3):559-567. PubMed ID: 30741811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.